Hospital Santa Marcelina, Sao Paulo, Brasil   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (1961)

Organization Overview

First Clinical Trial
2006
NCT00419081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Casa de Saúde santa Marcelina | Hospital Santa Marcelina | Igor Renato Louro Bruno de Abreu | Santa Marcelina Hospital | Sidnei Epelman

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 3)

Coronavirus Infections (Phase 2)

Dyslipidemias (Phase 4)

Hemorrhoids (Phase 3)

Hypertension (Phase 3)

Inflammation (Phase 2)

Ischemia (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Low Back Pain (Phase 3)

Lymphoma (Phase 2)

Neoplasms (Phase 2)

Osteosarcoma (Phase 2)

Philadelphia Chromosome (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Rhabdomyosarcoma (Phase 2)

Sarcoma (Phase 2)

Stroke (Phase 3)

Venous Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 15